Big Sioux Wealth Management’s Moleculin Biotech MBRX Stock Holding History
Bought
Maintained
Sold
Other funds holding MBRX
Big Sioux Wealth Management's MBRX Position: Q3 2026 in Review
Big Sioux Wealth Management increased its Moleculin Biotech (MBRX) stake by 113% in Q3 2026, buying an estimated $25.4K and bringing the position to 2,146 shares worth $21.5K. The position accounts for 0.01% of the portfolio, ranked #84.
Big Sioux Wealth Management first reported a position in MBRX in Q1 2026 and has held it in 3 quarters since. The position peaked at $56.1K in Q2 2026. 19 funds tracked by Wall St. Rank hold MBRX as of Q3 2026.
- Big Sioux Wealth Management held 2,146 shares of Moleculin Biotech worth $21.5K as of Q3 2026.
- Big Sioux Wealth Management bought 1,140 Moleculin Biotech shares in Q3 2026, an estimated $25.4K.
- Moleculin Biotech made up 0.01% of Big Sioux Wealth Management's portfolio in Q3 2026, its #84 holding.
- Big Sioux Wealth Management first reported a position in Moleculin Biotech in Q1 2026 and has held it in 3 quarters since.
- Big Sioux Wealth Management's Moleculin Biotech position peaked at $56.1K in Q2 2026.
- 19 funds tracked by Wall St. Rank held Moleculin Biotech as of Q3 2026.
Based on Big Sioux Wealth Management's 13F filing for Q3 2026, filed 19 Nov 2026.